American Association of Individual Investors11h
Why Solid Biosciences Inc.’s (SLDB) Stock Is Down 14.97%
Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.
Action News Now5d
Wellness Wednesday: NorCal man with rare disease cycles for a cure & how you can help
Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...
American Association of Individual Investors6d
Why Lexeo Therapeutics, Inc.’s (LXEO) Stock Is Down 10.14%
Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 10.14%, which has investors questioning if this is right time to buy.